Mental health starts with physical health: Current status and future directions of non-pharmacological interventions to improve physical health in first-episode psychosis

The Lancet Psychiatry

Volumn 2, Issue 8, 2015, Pages 726-742

  Gates, Jesse ^a   Killackey, Eóin ^b   Phillips, Lisa ^a   Álvarez Jiménez, Mario ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

BEHAVIOR CHANGE; BODY MASS; CONCEPTUAL FRAMEWORK; DIET; EARLY INTERVENTION; EXERCISE; FOLLOW UP; GENERAL CONDITION DETERIORATION; HEALTH BEHAVIOR; HUMAN; MENTAL HEALTH; PHYSICAL ACTIVITY; PSYCHOSIS; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SMOKING; SMOKING CESSATION; SOCIAL PSYCHOLOGY; SOCIOECONOMICS; WEIGHT GAIN; WEIGHT REDUCTION; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; DRUG EFFECTS; HEALTH PROMOTION; HEALTH STATUS; PROCEDURES; PSYCHOTIC DISORDERS; WEIGHT LOSS PROGRAM;

ANTIPSYCHOTIC AGENTS; CARDIOVASCULAR DISEASES; EXERCISE; HEALTH PROMOTION; HEALTH STATUS; HUMANS; MENTAL HEALTH; PSYCHOTIC DISORDERS; SMOKING; SMOKING CESSATION; WEIGHT GAIN; WEIGHT REDUCTION PROGRAMS;

EID: 84938230112     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(15)00213-8     Document Type: Review

References (132)

1. von Hausswolff-Juhlin Y, Bjartveit M, Lindström E, Jones P Schizophrenia and physical health problems. Acta Psychiatr Scand Suppl 2009, 119:15-21.
2. Foley DL, Morley KI Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Arch Gen Psychiatry 2011, 68:609-616.
3. Leucht S, Burkard T, Henderson J, Maj M, Sartorius N Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 2007, 116:317-333.
4. Galletly CA, Foley DL, Waterreus A, et al. Cardiometabolic risk factors in people with psychotic disorders: the second Australian national survey of psychosis. Aust N Z J Psychiatry 2012, 46:753-761.
5. Saha S, Chant D, McGrath J A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Arch Gen Psychiatry 2007, 64:1123-1131.
6. Laursen TM, Munk-Olsen T, Vestergaard M Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatry 2012, 25:83-88.
7. De Hert M, Correll CU, Bobes J, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 2011, 10:52-77.
8. Parks J, Svendsen D, Singer P, Foti ME Morbidity and mortality in people with serious mental illness. 13th technical report 2006, National Association of State Mental Health Program Directors Medical Directors Council, Alexandria, VA.
9. Tsoi DT, Porwal M, Webster AC Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev 2013, 2. CD007253.
10. Happell B, Davies C, Scott D Health behaviour interventions to improve physical health in individuals diagnosed with a mental illness: a systematic review. Int J Ment Health Nurs 2012, 21:236-247.
11. Bradshaw T, Lovell K, Harris N Healthy living interventions and schizophrenia: a systematic review. J Adv Nurs 2005, 49:634-654.
12. Alvarez-Jiménez M, Hetrick SE, González-Blanch C, Gleeson JF, McGorry PD Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry 2008, 193:101-107.
13. Bonfioli E, Berti L, Goss C, Muraro F, Burti L Health promotion lifestyle interventions for weight management in psychosis: a systematic review and meta-analysis of randomised controlled trials. BMC Psychiatry 2012, 12:78.
14. Hjorth P, Davidsen AS, Kilian R, Skrubbeltrang C A systematic review of controlled interventions to reduce overweight and obesity in people with schizophrenia. Acta Psychiatr Scand 2014, 130:279-289.
15. Bruins J, Jörg F, Bruggeman R, Slooff C, Corpeleijn E, Pijnenborg M The effects of lifestyle interventions on (long-term) weight management, cardiometabolic risk and depressive symptoms in people with psychotic disorders: a meta-analysis. PLoS One 2014, 9:e112276.
16. Alvarez-Jiménez M, González-Blanch C, Crespo-Facorro B, et al. Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal. CNS Drugs 2008, 22:547-562.
17. Scollo MM, Winstanley MH Tobacco in Australia: facts and issues 2012, Cancer Council Victoria, Melbourne, (accessed May 14, 2015). http://www.tobaccoinaustralia.org.au/downloads/chapters/Introduction.pdf.
18. Bradshaw T, Wearden A, Marshall M, et al. Developing a healthy living intervention for people with early psychosis using the Medical Research Council's guidelines on complex interventions: phase 1 of the HELPER - InterACT programme. Int J Nurs Stud 2012, 49:398-406.
19. Weighing the options: criteria for evaluating weight-management programs 1995, Institute of Medicine, National Academy Press, Washington, DC.
20. Reddy S Care pathway for the management of overweight and obesity 2006, UK National Health Service, London.
21. Alvarez-Jiménez M, González-Blanch C, Vázquez-Barquero JL, et al. Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: a randomized controlled trial. J Clin Psychiatry 2006, 67:1253-1260.
22. Alvarez-Jiménez M, Martínez-García O, Pérez-Iglesias R, Ramírez ML, Vázquez-Barquero JL, Crespo-Facorro B Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial. Schizophr Res 2010, 116:16-19.
23. Attux C, Martini LC, Elkis H, et al. A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia. BMC Psychiatry 2013, 13:60.
24. Bartels SJ, Pratt SI, Aschbrenner KA, et al. Clinically significant improved fitness and weight loss among overweight persons with serious mental illness. Psychiatr Serv 2013, 64:729-736.
25. Brar JS, Ganguli R, Pandina G, Turkoz I, Berry S, Mahmoud R Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry 2005, 66:205-212.
26. Curtis J, Watkins A, Rosenbaum S, et al. Evaluating an individualized lifestyle and life skills intervention to prevent antipsychotic-induced weight gain in first-episode psychosis. Early Interv Psychiatry 2015, published online Feb 26. 10.1111/eip.12230.
27. Daumit GL, Dickerson FB, Wang N-Y, et al. A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med 2013, 368:1594-1602.
28. Evans S, Newton R, Higgins S Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial. Aust N Z J Psychiatry 2005, 39:479-486.
29. Green CA, Janoff SL, Yarborough BJH, Yarborough MT A 12-week weight reduction intervention for overweight individuals taking antipsychotic medications. Community Ment Health J 2014, 50:974-980.
30. Jean-Baptiste M, Tek C, Liskov E, et al. A pilot study of a weight management program with food provision in schizophrenia. Schizophr Res 2007, 96:198-205.
31. Khazaal Y, Fresard E, Rabia S, et al. Cognitive behavioural therapy for weight gain associated with antipsychotic drugs. Schizophr Res 2007, 91:169-177.
32. Kwon JS, Choi J-SS, Bahk W-MM, et al. Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: a 12-week randomized controlled clinical trial. J Clin Psychiatry 2006, 67:547-553.
33. Littrell KH, Hilligoss NM, Kirshner CD, Petty RG, Johnson CG The effects of an educational intervention on antipsychotic-induced weight gain. J Nurs Scholarsh 2003, 35:237-241.
34. Lovell K, Wearden A, Bradshaw T, et al. An exploratory randomized controlled study of a healthy living intervention in early intervention services for psychosis: the INTERvention to encourage ACTivity, improve diet, and reduce weight gain (INTERACT) study. J Clin Psychiatry 2014, 75:498-505.
35. McKibbin CL, Patterson TL, Norman G, et al. A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res 2006, 86:36-44.
36. Mauri M, Simoncini M, Castrogiovanni S, et al. A psychoeducational program for weight loss in patients who have experienced weight gain during antipsychotic treatment with olanzapine. Pharmacopsychiatry 2008, 41:17-23.
37. Scocco P, Longo R, Caon F Weight change in treatment with olanzapine and a psychoeducational approach. Eat Behav 2006, 7:115-124.
38. Weber M, Wyne K A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophr Res 2006, 83:95-101.
39. Wu T, Gao X, Chen M, van Dam RM Long-term effectiveness of diet-plus-exercise interventions vs. diet-only interventions for weight loss: a meta-analysis. Obes Rev 2009, 10:313-323.
40. Alvarez-Jimenez M, Gonzalez-Blanch C Prevention of antipsychotic-induced weight gain in young people with psychosis: a multi-modal psychological intervention 2010, PubliCan, Ediciones de la Universidad de Cantabria, Santander.
41. Rössner S, Hammarstrand M, Hemmingsson E, Neovius M, Johansson K Long-term weight loss and weight-loss maintenance strategies. Obes Rev 2008, 9:624-630.
42. Baker A, Richmond R, Haile M, et al. A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. Am J Psychiatry 2006, 163:1934-1942.
43. Baker A, Richmond R, Lewin TJ, Kay-Lambkin F Cigarette smoking and psychosis: naturalistic follow up 4 years after an intervention trial. Aust N Z J Psychiatry 2010, 44:342-350.
44. Baker AL, Turner A, Kelly PJ, et al. 'Better Health Choices' by telephone: a feasibility trial of improving diet and physical activity in people diagnosed with psychotic disorders. Psychiatry Res 2014, 220:63-70.
45. Bernard PPN, Esseul EC, Raymond L, et al. Counseling and exercise intervention for smoking reduction in patients with schizophrenia: a feasibility study. Arch Psychiatr Nurs 2013, 27:23-31.
46. Bloch B, Reshef A, Cohen T, et al. Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia. Psychiatry Res 2010, 175:38-42.
47. Cather C, Dyer MA, Burrell HA, Hoeppner B, Goff DC, Evins AE An open trial of relapse prevention therapy for smokers with schizophrenia. J Dual Diagn 2013, 9:87-93.
48. Evins AE, Mays VK, Rigotti NA, Tisdale T, Cather C, Goff DC A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine Tob Res 2001, 3:397-403.
49. Gelkopf M, Noam S, Rudinski D, et al. Nonmedication smoking reduction program for inpatients with chronic schizophrenia: a randomized control design study. J Nerv Ment Dis 2012, 200:142-146.
50. Dale Horst W, Klein MW, Williams D, Werder SF Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia. Neuropsychiatr Dis Treat 2005, 1:349-355.
51. George TP, Ziedonis DM, Feingold A, et al. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry 2000, 157:1835-1842.
52. Steinberg ML, Ziedonis DM, Krejci JA, Brandon TH Motivational interviewing with personalized feedback: a brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. J Consult Clin Psychol 2004, 72:723-728.
53. Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Reid N Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology (Berl) 2011, 217:279-287.
54. Gilbody S, Peckham E, Man M-S, et al. Bespoke smoking cessation for people with severe mental ill health (SCIMITAR): a pilot randomised controlled trial. Lancet Psychiatry 2015, 2:395-402.
55. Banham L, Gilbody S Smoking cessation in severe mental illness: what works?. Addiction 2010, 105:1176-1189.
56. Phutane VH, Tek C, Chwastiak L, et al. Cardiovascular risk in a first-episode psychosis sample: a 'critical period' for prevention?. Schizophr Res 2011, 127:257-261.
57. Pérez-Iglesias R, Martínez-García O, Pardo-Garcia G, et al. Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors. Int J Neuropsychopharmacol 2014, 17:41-51.
58. WHO Part IV. Addressing the problem of overweight and obesity. Obesity: preventing and managing the global epidemic 2000, 153-238. WHO, World Health Organization, Geneva.
59. Myles N, Newall HD, Curtis J, Nielssen O, Shiers D, Large M Tobacco use before, at, and after first-episode psychosis: a systematic meta-analysis. J Clin Psychiatry 2012, 73:468-475.
60. Vangeli E, Stapleton J, Smit ES, Borland R, West R Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction 2011, 106:2110-2121.
61. Weiden PJ, Mackell JA, McDonnell DD Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res 2004, 66:51-57.
62. Faulkner G, Cohn T, Remington G, Irving H Body mass index, waist circumference and quality of life in individuals with schizophrenia. Schizophr Res 2007, 90:174-178.
63. Shrivastava A, Shah N, Johnston M, Stitt L, Thakar M Predictors of long-term outcome of first-episode schizophrenia: a ten-year follow-up study. Indian J Psychiatry 2010, 52:320-326.
64. Lee EH, Hui CL, Chang WC, et al. Impact of physical activity on functioning of patients with first-episode psychosis-a 6 months prospective longitudinal study. Schizophr Res 2013, 150:538-541.
65. Voruganti LNP, Whatham J, Bard E, et al. Going beyond: an adventure- and recreation-based group intervention promotes well-being and weight loss in schizophrenia. Can J Psychiatry 2006, 51:575-580.
66. Dome P, Lazary J, Kalapos MP, Rihmer Z Smoking, nicotine and neuropsychiatric disorders. Neurosci Biobehav Rev 2010, 34:295-342.
67. Vancampfort D, Wampers M, Mitchell AJ, et al. A meta-analysis of cardio-metabolic abnormalities in drug naive, first-episode and multi-episode patients with schizophrenia versus general population controls. World Psychiatry 2013, 12:240-250.
68. Connolly M, Kelly C Lifestyle and physical health in schizophrenia. Adv Psychiatr Treat 2005, 11:125-132.
69. Kumari V, Postma P Nicotine use in schizophrenia: the self medication hypotheses. Neurosci Biobehav Rev 2005, 29:1021-1034.
70. Barr AM, Procyshyn RM, Hui P, Johnson JL, Honer WG Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment. Schizophr Res 2008, 100:252-260.
71. Schmutte T, Flanagan E, Bedregal L, et al. Self-efficacy and self-care: missing ingredients in health and healthcare among adults with serious mental illnesses. Psychiatr Q 2009, 80:1-8.
72. Vancampfort D, De Hert M, Vansteenkiste M, et al. The importance of self-determined motivation towards physical activity in patients with schizophrenia. Psychiatry Res 2013, 210:812-818.
73. Verhaeghe N, De Maeseneer J, Maes L, Van Heeringen C, Annemans L Health promotion in mental health care: perceptions from patients and mental health nurses. J Clin Nurs 2013, 22:1569-1578.
74. Vancampfort D, Probst M, Scheewe T, et al. Relationships between physical fitness, physical activity, smoking and metabolic and mental health parameters in people with schizophrenia. Psychiatry Res 2013, 207:25-32.
75. Samele C, Patel M, Boydell J, Leese M, Wessely S, Murray R Physical illness and lifestyle risk factors in people with their first presentation of psychosis. Soc Psychiatry Psychiatr Epidemiol 2007, 42:117-124.
76. Revheim N, Schechter I, Kim D, et al. Neurocognitive and symptom correlates of daily problem-solving skills in schizophrenia. Schizophr Res 2006, 83:237-245.
77. Bergqvist A, Karlsson M, Foldemo A, Wårdig R, Hultsjö S Preventing the development of metabolic syndrome in people with psychotic disorders-difficult, but possible: experiences of staff working in psychosis outpatient care in Sweden. Issues Ment Health Nurs 2013, 34:350-358.
78. Samele C, Patel M, Boydell J, Leese M, Wessely S, Murray R. Physical illness and lifestyle risk factors in people with their first presentation of psychosis. Soc Psychiatry Psychiatr Epidemiol 42: 117-124.
79. Siru R, Hulse GK, Tait RJ Assessing motivation to quit smoking in people with mental illness: a review. Addiction 2009, 104:719-733.
80. Srinivasan TN, Thara R Smoking in schizophrenia-all is not biological. Schizophr Res 2002, 56:67-74.
81. Wood VJ, Curtis SE, Gesler W, et al. Spaces for smoking in a psychiatric hospital: social capital, resistance to control, and significance for 'therapeutic landscapes'. Soc Sci Med 2013, 97:104-111.
82. Drusch K, Lowe A, Fisahn K, et al. Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls. Eur Arch Psychiatry Clin Neurosci 2013, 263:519-527.
83. Williams JM, Ziedonis D Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav 2004, 29:1067-1083.
84. Herrán A, de Santiago A, Sandoya M, Fernández MJ, Díez-Manrique JF, Vázquez-Barquero JL Determinants of smoking behaviour in outpatients with schizophrenia. Schizophr Res 2000, 41:373-381.
85. Lyon ER A review of the effects of nicotine on schizophrenia and antipsychotic medications. Psychiatr Serv 1999, 50:1346-1350.
86. Campion J, Checinski K, Nurse J Review of smoking cessation treatments for people with mental illness. Adv Psychiatr Treat 2008, 14:208-216.
87. de Leon J, Diaz FJ A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 2005, 76:135-157.
88. Ghiasi F, Farhang S, Farnam A, Safikhanlou S The short term effect of nicotine abstinence on visuospatial working memory in smoking patients with schizophrenia. Nord J Psychiatry 2013, 67:104-108.
89. Kohen D Diabetes mellitus and schizophrenia: historical perspective. Br J Psychiatry Suppl 2004, 47:S64-S66.
90. Ryan MCM, Collins P, Thakore JH Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 2003, 160:284-289.
91. Ryan MC, Sharifi N, Condren R, Thakore JH Evidence of basal pituitary-adrenal overactivity in first episode, drug naive patients with schizophrenia. Psychoneuroendocrinology 2004, 29:1065-1070.
92. Gage SH, Munafò MR Rethinking the association between smoking and schizophrenia. Lancet Psychiatry 2015, 2:118-119.
93. Gurillo P, Jauhar S, Murray RM, MacCabe JH Does tobacco use cause psychosis? Systematic review and meta-analysis. Lancet Psychiatry 2015, published online July 10. http://dx.doi.org/10.1016/S2215-0366(15)00152-2.
94. Dixon LB, Dickerson F, Bellack AS, et al. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull 2010, 36:48-70. and the Schizophrenia Patient Outcomes Research Team (PORT).
95. Richardson CR, Faulkner G, McDevitt J, Skrinar GS, Hutchinson DS, Piette JD Integrating physical activity into mental health services for persons with serious mental illness. Psychiatr Serv 2005, 56:324-331.
96. Galletly CL, Murray LE Managing weight in persons living with severe mental illness in community settings: a review of strategies used in community interventions. Issues Ment Health Nurs 2009, 30:660-668.
97. Kalarchian MA, Marcus MD, Levine MD, et al. Behavioral treatment of obesity in patients taking antipsychotic medications. J Clin Psychiatry 2005, 66:1058-1063.
98. Beebe LH, Smith K, Burk R, et al. Motivational intervention increases exercise in schizophrenia and co-occurring substance use disorders. Schizophr Res 2012, 135:204-205.
99. Policy recommendations for smoking cessation and treatment of tobacco dependence 2003, WHO, World Health Organization, Geneva.
100. Cahill K, Lancaster T, Green N Stage-based interventions for smoking cessation. Cochrane Database Syst Rev 2010, 11. CD004492.
101. Medalia A, Saperstein A The role of motivation for treatment success. Schizophr Bull 2011, 37(suppl 2):S122-S128.
102. Medalia A, Brekke J In search of a theoretical structure for understanding motivation in schizophrenia. Schizophr Bull 2010, 36:912-918.
103. Ryan RM, Deci EL Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. Am Psychol 2000, 55:68-78.
104. Deci EL, Koestner R, Ryan RM A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation. Psychol Bull 1999, 125:627-668. discussion 692-700.
105. Williams GC, McGregor H, Sharp D, et al. A self-determination multiple risk intervention trial to improve smokers' health. J Gen Intern Med 2006, 21:1288-1294.
106. Silva MN, Vieira PN, Coutinho SR, et al. Using self-determination theory to promote physical activity and weight control: a randomized controlled trial in women. J Behav Med 2010, 33:110-122.
107. Silva MN, Markland D, Carraça EV, et al. Exercise autonomous motivation predicts 3-yr weight loss in women. Med Sci Sports Exerc 2011, 43:728-737.
108. Williams GC, McGregor HA, Zeldman A, Freedman ZR, Deci EL Testing a self-determination theory process model for promoting glycemic control through diabetes self-management. Health Psychol 2004, 23:58-66.
109. Fortier MS, Sweet SN, O'Sullivan TL, Williams GC A self-determination process model of physical activity adoption in the context of a randomized controlled trial. Psychol Sport Exerc 2007, 8:741-757.
110. Williams GC, McGregor HA, Sharp D, et al. Testing a self-determination theory intervention for motivating tobacco cessation: supporting autonomy and competence in a clinical trial. Health Psychol 2006, 25:91-101.
111. Mata J, Silva MN, Vieira PN, et al. Motivational "spill-over" during weight control: increased self-determination and exercise intrinsic motivation predict eating self-regulation. Health Psychol 2009, 28:709-716.
112. Moller AC, McFadden HG, Hedeker D, Spring B Financial motivation undermines maintenance in an intensive diet and activity intervention. J Obes 2012, 2012:740519.
113. Burns RJ, Donovan AS, Ackermann RT, Finch EA, Rothman AJ, Jeffery RW A theoretically grounded systematic review of material incentives for weight loss: implications for interventions. Ann Behav Med 2012, 44:375-388.
114. Breitborde NJK, Kleinlein P, Srihari VH Self-determination and first-episode psychosis: associations with symptomatology, social and vocational functioning, and quality of life. Schizophr Res 2012, 137:132-136.
115. Breitborde NJK, Woolverton C, Frost RB, Kiewel NA Self-determination theory and first-episode psychosis: a replication. Adv Psychiatr 2014, 2014:1-5.
116. Vancampfort D, Knapen J, Probst M, Scheewe T, Remans S, De Hert M A systematic review of correlates of physical activity in patients with schizophrenia. Acta Psychiatr Scand 2012, 125:352-362.
117. Vancampfort D, De Hert M, Stubbs B, et al. Negative symptoms are associated with lower autonomous motivation towards physical activity in people with schizophrenia. Compr Psychiatry 2015, 56:128-132.
118. Gard DE, Sanchez AH, Starr J, et al. Using self-determination theory to understand motivation deficits in schizophrenia: the 'why' of motivated behavior. Schizophr Res 2014, 156:217-222.
119. Kaleta D, Makowiec-Dabrowska T, Jegier A Employment status and self rated health. Int J Occup Med Environ Health 2008, 21:227-236.
120. Ferrie JE Is job insecurity harmful to health?. J R Soc Med 2001, 94:71-76.
121. Burgard SA, Brand JE, House JS Toward a better estimation of the effect of job loss on health. J Health Soc Behav 2007, 48:369-384.
122. Killackey E, Alvarez-Jimenez M, Allott K, Bendall S, McGorry P Community rehabilitation and psychosocial interventions for psychotic disorders in youth. Child Adolesc Psychiatr Clin N Am 2013, 22:745-758.
123. Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Davis JM Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev 2012, 5. CD008016.
124. Jarskog LF, Hamer MH, Catellier DJ, et al. Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder. Am J Psychiatry 2013, 170:1032-1040. and the METS Investigators.
125. Werneke U, Taylor D, Sanders TA Behavioral interventions for antipsychotic induced appetite changes. Curr Psychiatry Rep 2013, 15:347.
126. Alvarez-Jimenez M, Bendall S, Lederman R, et al. On the HORYZON: moderated online social therapy for long-term recovery in first episode psychosis. Schizophr Res 2013, 143:143-149.
127. Macias C, Panch T, Hicks YM, et al. Using smartphone apps to promote psychiatric and physical well-being. Psychiatr Q 2015, published online Jan 31. 10.1007/s11126-015-9337-7.
128. Fredrikson DH, Boyda HN, Tse L, et al. Improving metabolic and cardiovascular health at an early psychosis intervention program in Vancouver, Canada. Front Psychiatry 2014, 5:105.
129. De Hert M, Cohen D, Bobes J, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 2011, 10:138-151.
130. Hetrick S, Alvarez-Jiménez M, Parker A, et al. Promoting physical health in youth mental health services: ensuring routine monitoring of weight and metabolic indices in a first episode psychosis clinic. Australas Psychiatry 2010, 18:451-455.
131. Bradshaw T, Pedley R Evolving role of mental health nurses in the physical health care of people with serious mental health illness. Int J Ment Health Nurs 2012, 21:266-273.
132. Ryan RM, Patrick H, Deci EL, Williams GC Facilitating health behavior change and its maintenance: Interventions based on self-determination theory. Eur Health Psychol 2008, 10:2-5.